Free Trial
→ Elon’s Biggest Launch Ever: 15x Bigger Than SpaceX (From InvestorPlace) (Ad)tc pixel Free CSLLY Stock Alerts

CSL (CSLLY) Stock Forecast & Price Target

CSL logo
$21.81 -0.92 (-4.05%)
As of 05/7/2026 04:00 PM Eastern
Compare

CSL - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy
Based on 3 Analyst Ratings
Sell
0
Hold
2
Buy
1

Based on 3 Wall Street analysts who have issued ratings for CSL in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 3 analysts, 2 have given a hold rating, and 1 has given a strong buy rating for CSLLY.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CSLLY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CSL and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CSLLY Analyst Ratings Over Time

TypeCurrent Forecast
5/8/25 to 5/8/26		1 Month Ago
4/8/25 to 4/8/26		3 Months Ago
2/7/25 to 2/7/26		1 Year Ago
5/8/24 to 5/8/25
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
2 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus RatingModerate BuyModerate BuyBuyStrong Buy

CSLLY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CSLLY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CSL Stock vs. The Competition

TypeCSLMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.30
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted UpsideN/A841.15% Upside14.93% Upside
News Sentiment Rating
Neutral News

See Recent CSLLY News
Neutral News
Positive News
Export
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside		Details
2/11/2026
Royal Bank Of Canada logo
Royal Bank Of Canada
3 of 5 stars
 DowngradeModerate Buy ➝ Hold
12/29/2025
Zacks Research logo
Zacks Research
Not Rated
 UpgradeStrong Sell ➝ Hold
10/28/2025
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
4 of 5 stars
 UpgradeHold ➝ Strong-Buy
1/16/2025
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
D. Thillainathan
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
UpgradeStrong-Buy
8/13/2024
Macquarie Infrastructure Holdings, LLC logo
Macquarie Infrastructure
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
D. Bailey
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
UpgradeStrong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 07:02 AM ET.


Should I Buy CSL Stock? CSLLY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, May 6, 2026. Please send any questions or comments about these CSL pros and cons to contact@marketbeat.com.

CSL
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in CSL Limited:

  • The current stock price is around $79.55, which may present a favorable entry point for investors looking to capitalize on potential growth.
  • CSL Limited operates in the biopharmaceutical sector, which has shown resilience and growth potential, particularly in areas like gene therapies and plasma products.
  • The company has a diverse product portfolio across multiple segments, including CSL Behring, CSL Seqirus, and CSL Vifor, which helps mitigate risks associated with reliance on a single product line.
  • CSL Limited has a strong international presence, with operations in key markets such as the United States, Germany, and China, allowing for broader revenue opportunities.
  • Recent performance metrics indicate a positive trend, with a month-to-month change in shares shorted suggesting growing investor confidence.

CSL
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in CSL Limited for these reasons:

  • Institutional ownership is currently at 0%, which may indicate a lack of confidence from larger investors in the company's future prospects.
  • The short percentage of float is very low, suggesting that there may not be significant investor interest in betting against the stock, which could limit potential upside.
  • With an average daily volume of 139,400 shares, liquidity may be a concern for investors looking to enter or exit positions quickly.
  • The company has a relatively high number of shares shorted compared to its float, which could indicate potential volatility if there is a sudden shift in market sentiment.
  • CSL Limited's performance over the past year has been modest, with a 52-week performance increase of only about 0.25%, which may not meet the expectations of growth-oriented investors.

CSLLY Forecast - Frequently Asked Questions

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CSL in the last twelve months. There are currently 2 hold ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CSLLY shares.

According to analysts, CSL's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, CSL's stock had 1 downgrade by analysts.

CSL has been rated by research analysts at Royal Bank Of Canada in the past 90 days.

Analysts like CSL more than other "medical" companies. The consensus rating for CSL is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how CSLLY compares to other companies.

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With CSL Recommendations


This page (OTCMKTS:CSLLY) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners
Massive Data Leak Exposes 512,000-Line Code That Could Change Society Forever
"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
I’m sounding the alarm
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
One executive order. The biggest wealth transfer of your lifetime.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
The AI stocks about to become worthless (and one that isn't)
Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...
InvestorPlace | Sponsoredtc pixel